Catalyst Health Solutions, Inc. Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Glancy Bin...
April 18 2012 - 8:39PM
Business Wire
Glancy Binkow & Goldberg LLP announces that it is
investigating potential claims against the Board of Directors of
Catalyst Health Solutions, Inc. (“Catalyst” or the “Company”)
(NASDAQ: CHSI) related to the proposed acquisition of the Company
by SXC Health Solutions Corp. The cash-and-stock transaction
amounts to approximately $4.4 billion or $81.02 per share.
This investigation concerns whether the Board of Directors of
Catalyst breached their fiduciary duties to stockholders by failing
to adequately shop the Company before agreeing to enter into the
proposed transaction, and whether the Company has disclosed all
material information to shareholders about the transaction.
If you are a shareholder of Catalyst, if you have information or
would like to learn more about our investigation, or if you wish to
discuss these matters or have any questions concerning this
announcement or your rights or interests with respect to these
matters, please contact Louis Boyarsky, Esquire, Glancy Binkow
& Goldberg LLP, 1925 Century Park East, Suite 2100, Los
Angeles, CA 90067, by telephone at 310-201-9150 or Toll Free at
888-773-9224 or by email to shareholders@glancylaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
Catalyst Health Solutions, (MM) (NASDAQ:CHSI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catalyst Health Solutions, (MM) (NASDAQ:CHSI)
Historical Stock Chart
From Jul 2023 to Jul 2024